Clinical Trials List
2021-08-12 - 2022-04-26
Phase II/III
Terminated5
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/02/01
Investigators and Locations
Co-Principal Investigator
- Wang-Huei Sheng Division of Infectious Disease
- 劉旺達 Division of Infectious Disease
The Actual Total Number of Participants Enrolled
0 Stop recruiting
Co-Principal Investigator
- 楊家瑞 Division of Infectious Disease
The Actual Total Number of Participants Enrolled
0 Stop recruiting
Co-Principal Investigator
- 曾建豪 Division of Infectious Disease
The Actual Total Number of Participants Enrolled
0 Stop recruiting
Co-Principal Investigator
- Yu-Chao Lin Division of Thoracic Medicine
- Chih Hsueh Lin Division of Family Medicine
- Ho Mao-Wang Division of Infectious Disease
- 許原山
- 鄭宜昌 Division of Emergency Medicine
The Actual Total Number of Participants Enrolled
0 Stop recruiting
The Actual Total Number of Participants Enrolled
0 Stop recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
0 participants
-
Global
2246 participants
